BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37735030)

  • 1. Implementation status of prediction models for type 2 diabetes.
    Kishi A; Fukuma S
    Prim Care Diabetes; 2023 Dec; 17(6):655-657. PubMed ID: 37735030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic tools for cardiovascular disease in patients with type 2 diabetes: A systematic review and meta-analysis of C-statistics.
    Chowdhury MZI; Yeasmin F; Rabi DM; Ronksley PE; Turin TC
    J Diabetes Complications; 2019 Jan; 33(1):98-111. PubMed ID: 30446478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk prediction models for incident type 2 diabetes in Chinese people with intermediate hyperglycemia: a systematic literature review and external validation study.
    Xu S; Coleman RL; Wan Q; Gu Y; Meng G; Song K; Shi Z; Xie Q; Tuomilehto J; Holman RR; Niu K; Tong N
    Cardiovasc Diabetol; 2022 Sep; 21(1):182. PubMed ID: 36100925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of serum testosterone for type 2 diabetes risk assessment in men.
    Atlantis E; Fahey P; Martin S; O'Loughlin P; Taylor AW; Adams RJ; Shi Z; Wittert G
    BMC Endocr Disord; 2016 May; 16(1):26. PubMed ID: 27230668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary Prevention of Heart Failure in Patients With Type 2 Diabetes Mellitus.
    Greene SJ; Butler J
    Circulation; 2019 Jan; 139(2):152-154. PubMed ID: 30615507
    [No Abstract]   [Full Text] [Related]  

  • 6. High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.
    Wong YK; Cheung CYY; Tang CS; Hai JSH; Lee CH; Lau KK; Au KW; Cheung BMY; Sham PC; Xu A; Lam KSL; Tse HF
    Cardiovasc Diabetol; 2019 Dec; 18(1):171. PubMed ID: 31847896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Prediction for Early CKD in Type 2 Diabetes.
    Dunkler D; Gao P; Lee SF; Heinze G; Clase CM; Tobe S; Teo KK; Gerstein H; Mann JF; Oberbauer R;
    Clin J Am Soc Nephrol; 2015 Aug; 10(8):1371-9. PubMed ID: 26175542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple biomarker prediction of type 2 diabetes.
    Meigs JB
    Diabetes Care; 2009 Jul; 32(7):1346-8. PubMed ID: 19564478
    [No Abstract]   [Full Text] [Related]  

  • 9. The utility of diabetes risk score items as predictors of incident type 2 diabetes in Asian populations: An evidence-based review.
    Hu PL; Koh YL; Tan NC
    Diabetes Res Clin Pract; 2016 Dec; 122():179-189. PubMed ID: 27865165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of predictive risk models for major adverse cardiovascular events among patients with type 2 diabetes mellitus using health insurance claims data.
    Young JB; Gauthier-Loiselle M; Bailey RA; Manceur AM; Lefebvre P; Greenberg M; Lafeuille MH; Duh MS; Bookhart B; Wysham CH
    Cardiovasc Diabetol; 2018 Aug; 17(1):118. PubMed ID: 30143045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk assessment in type 2 diabetes mellitus: comparison of the World Health Organization/International Society of Hypertension risk prediction charts versus UK Prospective Diabetes Study risk engine.
    Herath HM; Weerarathna TP; Umesha D
    Vasc Health Risk Manag; 2015; 11():583-9. PubMed ID: 26622181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac Computed Tomography for Personalized Management of Patients With Type 2 Diabetes Mellitus.
    Cardoso R; Dudum R; Ferraro RA; Bittencourt M; Blankstein R; Blaha MJ; Nasir K; Rajagopalan S; Michos ED; Blumenthal RS; Cainzos-Achirica M
    Circ Cardiovasc Imaging; 2020 Sep; 13(9):e011365. PubMed ID: 32900225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a predictive model for incident type 2 diabetes in middle-aged Mexican adults: the metabolic syndrome cohort.
    Arellano-Campos O; Gómez-Velasco DV; Bello-Chavolla OY; Cruz-Bautista I; Melgarejo-Hernandez MA; Muñoz-Hernandez L; Guillén LE; Garduño-Garcia JJ; Alvirde U; Ono-Yoshikawa Y; Choza-Romero R; Sauque-Reyna L; Garay-Sevilla ME; Malacara-Hernandez JM; Tusie-Luna MT; Gutierrez-Robledo LM; Gómez-Pérez FJ; Rojas R; Aguilar-Salinas CA
    BMC Endocr Disord; 2019 Apr; 19(1):41. PubMed ID: 31030672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of mortality in hospital survivors with type 2 diabetes mellitus and acute coronary syndromes.
    Savonitto S; Morici N; Nozza A; Cosentino F; Perrone Filardi P; Murena E; Morocutti G; Ferri M; Cavallini C; Eijkemans MJ; Stähli BE; Schrieks IC; Toyama T; Lambers Heerspink HJ; Malmberg K; Schwartz GG; Lincoff AM; Ryden L; Tardif JC; Grobbee DE
    Diab Vasc Dis Res; 2018 Jan; 15(1):14-23. PubMed ID: 29052439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validating prediction scales of type 2 diabetes mellitus in Spain: the SPREDIA-2 population-based prospective cohort study protocol.
    Salinero-Fort MÁ; de Burgos-Lunar C; Mostaza Prieto J; Lahoz Rallo C; Abánades-Herranz JC; Gómez-Campelo P; Laguna Cuesta F; Estirado De Cabo E; García Iglesias F; González Alegre T; Fernández Puntero B; Montesano Sánchez L; Vicent López D; Cornejo Del Río V; Fernández García PJ; Sabín Rodríguez C; López López S; Patrón Barandío P;
    BMJ Open; 2015 Jul; 5(7):e007195. PubMed ID: 26220868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma metabolites associated with type 2 diabetes in a Swedish population: a case-control study nested in a prospective cohort.
    Shi L; Brunius C; Lehtonen M; Auriola S; Bergdahl IA; Rolandsson O; Hanhineva K; Landberg R
    Diabetologia; 2018 Apr; 61(4):849-861. PubMed ID: 29349498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of risk models to predict the 7-year risk of type 2 diabetes: The Japan Epidemiology Collaboration on Occupational Health Study.
    Hu H; Nakagawa T; Yamamoto S; Honda T; Okazaki H; Uehara A; Yamamoto M; Miyamoto T; Kochi T; Eguchi M; Murakami T; Shimizu M; Tomita K; Nagahama S; Imai T; Nishihara A; Sasaki N; Ogasawara T; Hori A; Nanri A; Akter S; Kuwahara K; Kashino I; Kabe I; Mizoue T; Sone T; Dohi S;
    J Diabetes Investig; 2018 Sep; 9(5):1052-1059. PubMed ID: 29380553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Prediction Tool To Identify Adults With Type 2 Diabetes at Risk for Persistent Adverse Glycemia in Hospital.
    Kyi M; Gorelik A; Reid J; Rowan LM; Wraight PR; Colman PG; Fourlanos S
    Can J Diabetes; 2021 Mar; 45(2):114-121.e3. PubMed ID: 33011129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver function tests and risk prediction of incident type 2 diabetes: evaluation in two independent cohorts.
    Abbasi A; Bakker SJ; Corpeleijn E; van der A DL; Gansevoort RT; Gans RO; Peelen LM; van der Schouw YT; Stolk RP; Navis G; Spijkerman AM; Beulens JW
    PLoS One; 2012; 7(12):e51496. PubMed ID: 23284703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examining the relationship between HbA1c and diabetes risk models in a European population indicates a lower threshold to identify 'high risk' is required.
    Gray BJ; Bracken RM; Turner D; Morgan K; Thomas M; Williams SP; Williams M; Rice S; Stephens JW;
    Diab Vasc Dis Res; 2016 May; 13(3):228-35. PubMed ID: 26956443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.